Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
RegoNivo vs Standard of Care Chemotherapy in AGOC - Drug Trials For Money - Paid Clinical Trials

RegoNivo vs Standard of Care Chemotherapy in AGOC

RegoNivo vs Standard of Care Chemotherapy in AGOC
Condition:   Gastro-Oesophageal Cancer
Interventions:   Drug: Regorafenib;   Biological: Nivolumab;   Drug: Docetaxel;   Drug: Paclitaxel;   Drug: Irinotecan;   Drug: Trifluridine/Tipracil
Sponsors:   Australasian Gastro-Intestinal Trials Group;   Bayer;   Bristol-Myers Squibb;   University of Sydney;   Academic and Community Cancer Research United;   Taiwanese Cooperative Oncology Group;   Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 31, 2021 / by / in
Comments